Key facts
- Notable investors include CAS Star, Cybernaut (China) Investment, Danen Capital, R-Z Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Jingtong Life
- ·The full record, as it builds
Funding rounds
No funding rounds for Jingtong Life are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jingtong Life
Provider of research and experimental development services intended for businesses and research entities. The company offers technical services, technical development, technical consultation, technical exchange, technology transfer, technology promotion, sales of chemical products, and research and development of biochemical product technology, enabling customers to access structured research and development capabilities.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Jingtong Life doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jingtong Life shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jingtong Life in its N-PORT filings yet. We sweep new filings monthly.